| Bioactivity | LY2880070 is an orally active CHK1 inhibitor. LY2880070 can be used as an anticancer agent for combination with DNA damaging agents[1]. |
| Target | 1375637-35-6 |
| Name | LY2880070 |
| CAS | 1375637-35-6 |
| Formula | C19H23N7O2 |
| Molar Mass | 381.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Quincy S, et al. A phase Ib study of oral Chk1 inhibitor LY2880070 in combination with gemcitabine in patients with advanced or metastatic cancer. Journal of Clinical Oncology 2020 38:15_suppl, 3581. |
LY2880070
CAS: 1375637-35-6 F: C19H23N7O2 W: 381.43
LY2880070 is an orally active CHK1 inhibitor. LY2880070 can be used as an anticancer agent for combination with DNA dama
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.